Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Senzime AB ( (SE:SEZI) ) is now available.
Senzime AB announced that its CEO, Philip Siberg, will present at the European Growth Virtual Investor Conference on September 11, 2025. This event provides an opportunity for investors to engage with the company in real-time, potentially impacting Senzime’s visibility and investor relations in the healthcare monitoring industry.
The most recent analyst rating on (SE:SEZI) stock is a Hold with a SEK6.50 price target. To see the full list of analyst forecasts on Senzime AB stock, see the SE:SEZI Stock Forecast page.
More about Senzime AB
Senzime is a leading medical device company focused on precision-based monitoring systems that enhance patient safety during anesthesia. Established in 1999 and headquartered in Uppsala, Sweden, the company is known for its TetraGraph® system, which is widely used in operating rooms globally for accurate neuromuscular transmission monitoring. Senzime is publicly traded on the Nasdaq Stockholm and the US OTCQX Market.
YTD Price Performance: 17.45%
Average Trading Volume: 495,849
Technical Sentiment Signal: Hold
Current Market Cap: SEK1.02B
For a thorough assessment of SEZI stock, go to TipRanks’ Stock Analysis page.